PHASQ
vs
GILD
PHASQ
GILD
Over the past 12 months, PHASQ has underperformed GILD, delivering a return of 0% compared to the GILD's +43% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
PHASQ
GILD
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
|
0.0001
USD
|
|||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
136.09
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
PHASQ, GILD
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
PhaseBio Pharmaceuticals Inc
Revenue
|
|||||||||||
|
Gilead Sciences Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
PHASQ, GILD
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
|
|||||||||
|
Gilead Sciences Inc
NASDAQ:GILD
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc | ||||
|
Gilead Sciences Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
PHASQ, GILD
Performance Gap
PHASQ, GILD
Performance By Year
PHASQ, GILD
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.